microRNA-370-5p inhibits non-small cell lung cancer cell proliferation and migration and promotes apoptosis by targeting KPNA3
Keywords:
MicroRNA-370-5p, KPNA3, Non-small cell lung cancer, Proliferation, MigrationAbstract
This study aimed to investigate the biological function of microRNA-370-5p (miR-370-5p) in non-small cell lung cancer (NSCLC) and its regulatory relationship with KPNA3. The expression levels of miR-370-5p and KPNA3 were examined in 72 NSCLC tissue samples and matched adjacent non-tumor tissues, as well as in cell lines (BEAS-2B, A549, H1299, and H460). A549 cells were transfected with miR-370-5p mimic, miR-370-5p inhibitor, or KPNA3 overexpression plasmids. Cell viability was assessed using the CCK-8 assay, migration was measured by Transwell assays, and apoptosis was evaluated via flow cytometry. Dual-luciferase reporter assays confirmed the direct binding between miR-370-5p and KPNA3. miR-370-5p was down-regulated, whereas KPNA3 was upregulated in NSCLC tissues and cells. Overexpression of miR-370-5p inhibited cell proliferation and migration and increased apoptotic rates, while inhibition of miR-370-5p inhibition exerted opposite effects. KPNA3 overexpression partially reversed the effects of miR-370-5p, indicating that KPNA3 functions as a downstream effector of miR-370-5p. miR-370-5p suppresses NSCLC cell growth and migration while promoting apoptosis by directly targeting KPNA3.
0
0
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomata-ram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74: 229-63.
Chang JM, Kam KH, Chao WY, Zhao PW, Chen SH, Chung HC, Li YZ, Wu JY, Lee YR. Berberine derivatives suppress cellular proliferation and tumorigenesis in vitro in human non-small-cell lung cancer cells. Int J Mol Sci. 2020; 21: 4218.
Chen T, Gao F, Feng S, Yang T, Chen M. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4. Oncol Rep. 2015; 34: 461-68.
Chen X, Liu Y, Zhang Q, Liu B, Cheng Y, Zhang Y, Sun Y, Liu J, Gen H. Exosomal long non-coding RNA HOTTIP increases resistance of colorectal cancer cells to mitomycin via impairing MiR-214-mediated degradation of KPNA3. Front Cell Dev Biol. 2020; 8: 582723.
Chen X, Wei H, Yue A, Zhang H, Zheng Y, Sun W, Zhou Y, Wang Y. KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes. Sci Rep. 2024; 14: 17140.
Choi J, Choi JH, Lee HW, Seo D, Lkhagvasuren G, Kim JW, Seo SB, Lee K, Lee KH. KPNA3 promotes epithelial-mesenchymal transition by regulating TGF-beta and AKT signaling pathways in MDA-MB-231, a triple-negative breast cancer cell line. BMB Rep. 2023; 56: 120-25.
El Founini Y, Chaoui I, Dehbi H, El Mzibri M, Abounader R, Guessous F. MicroRNAs: Key regulators in lung cancer. Microrna 2021; 10: 109-22.
Feng F, Yang J, Chen A, Cui M, Li L. Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis. J Tissue Eng Regen Med, 2022; 16: 575-85.
Hu D, Shen W, Gong C, Fang C, Yao C, Zhu X, Wang L, Zhao C, Zhu S. Grain-sized moxibustion promotes NK cell anti-tumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer. J Cell Mol Med, 2021; 25: 2900-08.
Hu Y, Zhou J, Ling X, Zhao K, Huang P, Gao M., Li X, Sun M, Zou Y, Feng G. KPNA5 suppresses malignant progression of ovarian cancer through importing the PTPN4 into the nucleus. Cancer Med. 2025; 14: e70731.
Ji D, Hou L, Xie C, Feng H, Bao D, Teng Y, Liu J, Cui T, Wang X, Xu Y, Tan G. Deoxyelephantopin suppresses pancreatic cancer progression in vitro and in vivo by targeting linc00511/miR-370-5p/p21 promoter axis. J Oncol. 2022; 3855462.
Kehlenbach RH, Neumann P, Ficner R, Dickmanns A. Interaction of nucleoporins with nuclear transport receptors: A structural perspective. Biol Chem. 2023; 404: 791-805.
Leonard A, Rahman A, Fazal F. Importins alpha and beta signaling mediates endothelial cell inflammation and barrier disruption. Cell Signal. 2018; 44: 103-17.
Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K., Chen Z. Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells. Tumour Biol. 2017; 39: 1010428317710824.
Liao M, Peng L. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C. Cell Mol Biol Lett. 2020; 25: 22.
Lobera ES, Varela MA, Jimenez RL, Moreno RB. miRNA as biomarker in lung cancer. Mol Biol Rep. 2023; 50: 9521-27.
Oka M, Yoneda Y. Importin alpha: Functions as a nuclear transport factor and beyond. Proc Jpn Acad Ser B Phys Biol Sci. 2018; 94: 259-74.
Samson JS, Parvathi VD. Prospects of microRNAs as thera-peutic biomarkers in non-small cell lung cancer. Med Oncol. 2023; 40: 345.
Shen W, Hong X, Jin C, Xi Y. LncRNA PSMG3AS1 promotes proliferation of non-small cell lung cancer cells by sponging miR-613 to upregulate SphK1. Cell Cycle. 2021; 20: 829-38.
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74: 12-49.
Sun B, Zhao J, Shao ZY. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2. Eur Rev Med Pharmacol Sci. 2022; 26: 3083-90.
Tang Z, Jiang Y, Ding S, Jiang S, Tang R, Luo P. miR-370 impacts the biological behavior of lung cancer cells by targeting the SMAD1 signaling pathway. Am J Transl Res. 2022; 14: 8117-28.
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epi-demiology of lung cancer. Contemp Oncol (Pozn). 2021; 25: 45-52.
Wang XW, Jiang YH, Ye W, Shao CF, Xie JJ, Li X. SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53/miR-101/KPNA3 axis. Cancer Biol Ther. 2023; 24: 2235770.
Xiao Z, Liu X, Lodish HF. Importin beta mediates nuclear translocation of Smad 3. J Biol Chem. 2000; 275: 23425-28.
Xu P, Ding Y, Mo B, Wang L, Hu F, Yang Q, Jiang L, Xiao H, Ding F. Downregulation hsa_circ_0000571 inhibited the malignant progression of NSCLCs by regulation miR-654-5p/S100A11 axis. Int Immunopharmacol. 2025; 163: 115137.
Ye L, Wang J, Yi K, Wang F, Wang J, Wu H, Yang H, Yang Z, Zhang QA. Recent findings on miR‑370 expression, regulation and functions in cancer (Review). Oncol Rep. 2023; 49: 79.
Zhang K, Han X, Hu W, Su C, He B. miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/beta-catenin signaling pathway. Oncol Lett. 2022; 24: 379.
Zhang MY, Lin J, Kui YC. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1. Eur Rev Med Pharmacol Sci. 2019; 23: 2436-43.
Zhao HS, Tao XM, Wang Q, Fang YY, Zhang HY, Wang HQ, Zhang GJ. Silencing SIX1 by miR-7160 inhibits non-small cell lung cancer cell growth. Aging (Albany NY). 2021; 13: 8055-67.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zhouli Ding, Yali Yang, Jingjing Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
